Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
January 1, 2017
Primary Completion Date
July 1, 2023
Study Completion Date
September 30, 2024
Conditions
Colorectal Cancer
Trial Locations (1)
510060
Sun Yat-sen University, Cancer Center, Guangzhou
All Listed Sponsors
lead
Sun Yat-sen University
OTHER
NCT06717763 - Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer | Biotech Hunter | Biotech Hunter